United States · FDA National Drug Code directory
Levothyroxine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-3116_03c8c731-bb36-40e0-bd9d-8a90c31c3301
- Product NDC
- 71335-3116
- Form
- TABLET
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190320
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — .15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71335-3116-1) · 71335-3116-1
- 100 TABLET in 1 BOTTLE (71335-3116-2) · 71335-3116-2
- 90 TABLET in 1 BOTTLE (71335-3116-3) · 71335-3116-3
- 60 TABLET in 1 BOTTLE (71335-3116-4) · 71335-3116-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →